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Abstract
Genomic imprinting is an epigenetic process leading to parent-of-origin–specific DNA methylation and gene expression. To
date, ,60 imprinted human genes are known. Based on genome-wide methylation analysis of a patient with multiple
imprinting defects, we have identified a differentially methylated CpG island in intron 2 of the retinoblastoma (RB1) gene on
chromosome 13. The CpG island is part of a 59-truncated, processed pseudogene derived from the KIAA0649 gene on
chromosome 9 and corresponds to two small CpG islands in the open reading frame of the ancestral gene. It is methylated
on the maternal chromosome 13 and acts as a weak promoter for an alternative RB1 transcript on the paternal chromosome
13. In four other KIAA0649 pseudogene copies, which are located on chromosome 22, the two CpG islands have
deteriorated and the CpG dinucleotides are fully methylated. By analysing allelic RB1 transcript levels in blood cells, as well
as in hypermethylated and 5-aza-29-deoxycytidine–treated lymphoblastoid cells, we have found that differential
methylation of the CpG island skews RB1 gene expression in favor of the maternal allele. Thus, RB1 is imprinted in the
same direction as CDKN1C, which operates upstream of RB1. The imprinting of two components of the same pathway
indicates that there has been strong evolutionary selection for maternal inhibition of cell proliferation.
Citation: Kanber D, Berulava T, Ammerpohl O, Mitter D, Richter J, et al. (2009) The Human Retinoblastoma Gene Is Imprinted. PLoS Genet 5(12): e1000790.
doi:10.1371/journal.pgen.1000790
Editor: Lisa Stubbs, University of Illinois at Urbana-Champaign, United States of America
Received August 6, 2009; Accepted November 25, 2009; Published December 24, 2009
Copyright:  2009 Kanber et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Supported by grants from the Deutsche Forschungsgemeinschaft (KFO 109 Lo530/5-4), Bundesministerium fu ¨r Bildung und Forschung (Network
Imprinting diseases) (01GM0882-886), and the KinderKrebsInitiative Buchholz/Holm-Seppensen. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: bernhard.horsthemke@uni-due.de
. These authors contributed equally to this work.
Introduction
Genomic imprinting is an epigenetic process leading to parent-
of-origin specific DNA methylation and gene expression [1,2].
Imprints are established during gametogenesis, maintained after
fertilization and erased in primordial germ cells (for a recent
review see Wood and Oakey, 2006) [3]. It is still a matter of
debate, how and why genomic imprinting evolved. The most
favoured theory is the kinship theory [4], which postulates a tug-
of-war between the two parental genomes over maternal resources
during pregnancy and early childhood. As predicted by the kinship
theory, several imprinted genes are known to regulate cell
proliferation and fetal growth.
To date, ,60 imprinted human genes are known (http://www.
geneimprint.com/). Based on DNA sequence features, Luedi et al.
[5] have estimated that there might be some 600 imprinted genes in
the mouse. It is likely that a similar number of imprinted genes exist
in the human genome. There are at least two reasons why it is
difficult to determine the actual number of imprinted genes: (i)
imprinted expression can be tissue-specific and (ii) is not always an
all-or-nothing phenomenon.The identification ofimprintedgenes in
humans is even more challenging due to experimental limitations.
On the otherhand, naturally occurring imprinting defects have been
identified in human patients, but are unknown in mice. These
imprinting defects provide a unique opportunity to identify im-
printing control elements, imprinting factors and imprinted genes.
Roughly speaking, imprinting defects are either primary
epimutations that occur in the absence of a DNA mutation or
secondary epimutations that result from a DNA mutation [6].
Whereas a DNA mutation in an imprinting control region results
in a secondary imprinting defect in cis, a DNA mutation affecting
an imprinting factor typically affects the imprint at several loci in
trans.
Recently we have observed a patient with hypomethylation of
all imprinted loci tested (Caliebe, Siebert et al., in preparation; for
clinical details see Materials and Methods). Based on genome-wide
methylation analysis of this patient as described here we have
found that the RB1 gene is imprinted. RB1, a tumor suppressor
gene for the childhood tumor retinoblastoma (accession
no. NM_000321) [7], encodes a nuclear phosphoprotein, pRb
[8]. When hypo-phosphorylated, pRb acts as a transcriptional
cofactor and, by recruiting chromatin remodelling enzymes,
represses the proliferation-promoting activities of a subset of E2F
transcription factors [7]. Phosphorylation by activated cyclin-
dependent kinases (CDKs) results in derepression and activation of
E2F dependent promoters. CDK inhibitors such as CDKN1C
inhibit this process. In addition to control the G1-S cell cycle
transition, pRb has important roles in embryogenesis and
maintenance of trophoblast stem cells [9].
Parent-of-origin effects have been reported in human pheno-
types associated with mutations of the RB1 gene. These include
differential penetrance and age at onset in retinoblastoma and an
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osteosarcoma [10–12]. However, as the CpG island/exon 1 region
is not known to be imprinted [13], the mechanisms underlying
these effects have been unclear.
Results/Discussion
In order to identify novel imprinted loci, we performed genome-
wide CpG methylation analysis (Infinium HumanMethylation27
BeadChip, Illumina) in DNA from blood of a patient with multiple
imprinting defects and appropriate controls. This confirmed
hypomethylation of known imprinted loci and, moreover,
identified additional loci hypomethylated in the propositus. One
of these loci on the array is a 1.2 kb CpG island within intron 2 of
the RB1 gene (CpG 85, UCSC browser, chr13:48,892,636–
48,893,857, hg19, http://genome.ucsc.edu; Figure 1A).
An NCBI Blast search (human build 37 genome data base,
http://blast.ncbi.nlm.nih.gov/Blast.cgi) revealed that CpG 85 is
part of a 4.5 kb region with a high sequence identity (87%) to exon
4 and 18 bp of the 39 end of exon 3 of KIAA0649 (accession
no. NM_014811), a four-exon gene in 9q34.3 that encodes a 1209
amino acids protein of unknown function [14]. Four additional
intronless copies of KIAA0649, each with 89% sequence identity to
exons 2 to 4 of the ancestral gene, are located in close proximity to
each other on chromosome 22q11.21 (Figure 2). The open reading
frame (ORF), which is located in exon 4 of the ancestral gene, is
lost in all five processed copies (http://www.ncbi.nlm.nih.gov/
gorf/gorf.html). These data suggest that independent retrotrans-
position events resulted in integration of two processed pseudo-
genes with different extent of 59 truncation, one on chromosome
13 and the other on chromosome 22, and that further copies on
chromosome 22 are due to gene duplication.
The four small (,300bp) CpG islands present in exon 4 of
KIAA0649 are not present in the pseudogene copies on
chromosome 22 but appear to have evolved into two CpG islands
(CpG 85 and CpG 42) following integration into the RB1 gene.
Specifically, CpG 85, which spans 1.2 kb, corresponds to the small
islands CpG 19 and CpG 17 at the KIAA0649 locus, which only
contain 229 bp and 209 bp, respectively.
By in silico analyses (UCSC genome browser and BLAT search)
we have found that the processed pseudogene with the CpG island
is also present in the RB1 gene of chimpanzee and rhesus, but not
in the Rb1 gene of mice and rat. As shown in Figure 2, the
situation in chimpanzee resembles that in humans with the
exception that there is an additional pseudogene copy on
chromosome 8, which has a CpG island (CpG 73) of 1.1 kb,
and that there are only three pseudogene copies on chromosome
22. In the rhesus the situation is different in that the KIAA0649
homologue has a CpG island (CpG 99) of 1.5 kb and that there
are no other pseudogene copies in the genome apart from the copy
within intron 2 of the RB1 gene, which has a 578 bp CpG island
(CpG 39). Based on these data it is possible that the human CpG
85 island has not evolved from two small CpG islands in the ORF
of KIAA0649, but that a big CpG island in this gene was
maintained in the processed pseudogene located within RB1, but
Author Summary
Genomic imprinting is an epigenetic process leading
to parent-of-origin–specific DNA methylation and gene
expression. Defects in this process lead to abnormal
development, growth, or behavior. It is still unclear why
and how imprinting evolved and how many human genes
are imprinted. Based on genome-wide DNA methylation
analysis in a patient with a generalized imprinting defect,
we have found that the paradigmatic retinoblastoma 1
(RB1) gene on chromosome 13 is imprinted. Imprinting of
RB1 is linked to the insertion of a DNA sequence derived by
retrotransposition from a gene on chromosome 9. Part of
the inserted DNA sequence has evolved into a differentially
methylated alternative RB1 promoter. Differential methyla-
tion of this sequence skews expression of the RB1 gene in
favour of the maternal allele. The direction of the imprint
imposed on the RB1 gene is the same as of the maternally
expressed CDKN1C gene, which operates upstream of RB1.
The imprinting of two components of the same pathway
indicates that there has been strong evolutionary selection
for maternal inhibition of cell proliferation.
Figure 1. Identification of a novel putative imprinted locus. (A) Heatmap of the Infinium HumanMethylation27 BeadChip (Illumina) for the
RB1 gene. The CpG sites representing CpG 85 show about 50% methylation in DNA from blood of the parents but are hypomethylated in DNA from
blood of the patient. In all samples, CpG 42 is methylated and CpG 106 is unmethylated. Target ID of the CpG sites representing CpG 85: cg19427472,
cg13431205, cg03085377, cg18481241; CpG 42: cg19447496, cg19296958; CpG 106: cg24937706, cg10552385, cg17055959. (B) Schematic
representation of the 59-region of the RB1 locus (not drawn to scale) and location of CpG islands (green boxes). Regular exons are shown in blue
whereas the new exon 2B is shown in light blue. Open lollipops, unmethylated CpGs; filled lollipops, methylated CpGs; black arrows, transcription
start sites. (C) Exon connection PCR. M, DNA length standard; +, with RT; 2, without RT; arrowhead indicates the RT–PCR product that was used as
template for sequencing; red arrows, location of RT–PCR primers.
doi:10.1371/journal.pgen.1000790.g001
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copies in the human and chimpanzee lineage after the retrotrans-
position events. Irrespective of whether evolution has shaped or
maintained the CpG island within intron 2 of the RB1 gene, it has
acquired a new function (see below).
To find out whether CpG 85 is differentially methylated in a
parent-of-origin specific manner, we studied 12 CpG dinucleotides
after bisulfite treatment, cloning and sequencing of blood DNA
from a normal individual and from five retinoblastoma patients
with whole RB1 gene deletions of known parental origin. Because
of the high sequence identity between the repetitive sequences, the
248 bp PCR product obtained for subcloning was not specific for
the chromosome 13 copy so that sequence differences were used to
assign the clones to the different chromosomal regions. By this we
found that the chromosome 9 and 22 sequences are fully
methylated (data not shown). In contrast, CpG sites in CpG 85
clones from the normal control were either methylated or
unmethylated (Figure 3A). Almost all clones from the two patients
with a maternal RB1 gene deletion were derived from unmethy-
lated sequences, whereas the sequence of all clones from the three
patients with a paternal deletion indicated fully methylated CpG
sites (Figure 3A). We conclude that CpG 85 shows parent-of-origin
specific methylation – it is methylated on the maternal
chromosome 13 and unmethylated on the paternal chromosome
13. Methylation analysis of two independent sperm samples
revealed that the CpG 85 is unmethylated in male germ cells (data
not shown).
We also analyzed the CpG island in intron 2 of the chimpanzee
RB1 gene (CpG 87; see Figure 2). Of 29 bisulfite clones sequenced,
twelve were derived from methylated sequences, 16 were derived
from unmethylated sequences, and one was derived from a
partially methylated sequence (data not shown). These findings
indicate that the CpG island in intron 2 of the RB1 gene is
differentially methylated in the chimpanzee also.
To find out if CpG 85 acts as a promoter for an antisense
transcript, as is the case for the differentially methylated CpG
islands associated with the Zrsr1(U2af1-rs1) and Nnat genes, for
example, which are located in intron 1 of the Commd1 and Blcap
genes, respectively [15,16], we tried to link a spliced antisense EST
clone upstream of exon 1 of the RB1 gene with an unspliced
antisense EST clone overlapping with CpG 85. As these
experiments as well as 59-a n d3 9-RACE (Rapid Amplification of
cDNA ends) did not provide any evidence for an antisense
transcript, we searched for an alternative sense transcript by exon-
connection RT–PCR of CpG 85 and exon 3 and exon 4 of the RB1
gene. Sequence analysis of the products showed that the CpG island
contains a novel start exon (exon 2B) that is spliced onto exon 3 of
the RB1gene. Three putative transcription start sites were identified
by 59-RACE experiments and, depending on which of them is used,
the new exon 2B (Figure 1B) has a size of 478 bp (48893574–
48894051), 632 bp (48893420–48894051) or 1159 bp (48892893–
48894051). RT–PCR analysis revealed that the 2B-transcript is
present at very low levels in many tissues (Figure 4).
We sought to test if parent-of-origin specific methylation of
CpG 85 is coupled with monoallelic expression of the 2B-
transcript, but as expressed single nucleotide polymorphisms are
rare in the RB1 gene we had to draw on rare variants identified
during diagnostic mutation analysis (Table 1). RNA from blood
was available from a patient heterozygous for a maternally
inherited variant in exon 3 (family A, Figure 3B). Sequence
analysis of RT–PCR products specific for the 2B-transcript
showed only the C allele, which is of paternal origin.
The identification of an alternative RB1 transcript made from
the paternal allele only raised the question whether it is made
Figure 2. Structure of KIAA0649 and processed pseudogenes in human (position numbers according to hg19, UCSC), chimpanzee
(panTro2, UCSC), and rhesus (rheMac2, UCSC). In the human genome, two of the four small CpG islands in exon 4 of KIAA0649 (CpG 19 and
CpG 17) correspond to CpG 85 in the chromosome 13 copy. The other two (CpG 26 and CpG 19) correspond to CpG 42. The figure also shows the
similarities and differences between the situation in humans, chimpanzee and rhesus. Owing to gaps in the chimpanzee and rhesus genome
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transcript. If so, the total level of paternal RB1 transcripts should
be higher compared to that of the maternal transcripts. We
investigated this by fluorescence-tagged primer extension analyses
of blood RNA from 14 individuals heterozygous for expressed
sequence variants of known (n=12) or likely (n=2) parental origin
(Table 1 and Figure 5). We found allelic expression imbalance in
all individuals (2.7616%, ratio6SD) (Figure 5), but in all cases the
imbalance was in favour of the maternal allele. This finding
suggested that lack of methylation of CpG 85 and possibly
expression of the 2B-transcript interferes with the expression of the
regular transcript from the same, i.e. paternal allele. To test this
hypothesis, we treated lymphoblastoid cells (LCs) with 5-aza-29-
deoxycytidine (AzadC), which inhibits the DNA methyltransferase
DNMT1. Bisulfite sequencing showed that the CpG island
associated with the regular RB1 promoter, CpG 106, was
unmethylated in untreated and treated LCs (data not shown).
For quantitative analysis of CpG 85 methylation, we established a
methylation-specific (MS)-PCR assay. By this we found that in
some LCs CpG 85 methylation was greater than 50% (Figure 6A,
upper panel). In all cell cultures AzadC treatment had the
intended effect of partial loss of methylation at CpG 85.
First, we investigated whether demethylation of CpG 85
resulted in activation of transcription from the maternal 2B-
promoter. Analysis of LCs from family A showed that expression
of the 2B-transcript remained monoallelic after mock-treatment,
as expected (Figure 6B). In two independent experimental rounds,
LCs from individuals A II-1 and A III-1 gained biparental
expression of the 2B-transcript after demethylation treatment
(Figure 6B), although in several assays the expression levels of 2B-
transcripts were low or below the detection limit.
Next, we investigated the ratio of the parental RB1 transcripts.
All cell cultures treated with AzadC showed reduced skewing of
the allelic RB1 transcripts (1.4614%, ratio6SD; Figure 6A, lower
panel). The reduction in skewing most likely results from the fact
that in many cells the maternal allele has lost methylation and now
resembles the paternal allele. Reduced skewing was also observed
in the mock-treated LCs (1.7628%, ratio6SD), which showed
some increase in CpG 85 methylation compared to fresh blood.
Although there was no strict quantitative correlation between the
degree of hypermethylation and the degree of reduction in skewing
(Figure 6A, upper panel), the effect was most prominent in LCs
from individuals AII-1 and HII-1, which have the highest degree
Figure 4. Expression profile of the 2B-transcript. The 2B-
transcript is expressed in all of the tissues studied.
doi:10.1371/journal.pgen.1000790.g004
Figure 3. Analysis of CpG 85 and the 2B-transcript. (A) Methylation analysis of CpG 85 by DNA cloning and sequencing. A total of 12 CpG sites
within the CpG island were analyzed. Clones from a normal control (blood DNA) were derived from almost fully methylated or unmethylated
sequences. Almost all clones from blood DNA from two patients with a deletion of the maternal RB1 allele were derived from unmethylated
sequences, whereas clones obtained from three patients with a paternally derived RB1 deletion were derived from almost fully methylated
sequences. Each block of clones represents an individual. Open circles, unmethylated CpGs; filled circles, methylated CpGs. (B) Allelic expression
analysis of the 2B-transcript in blood of a patient heterozygous for a rare variant in exon 3 inherited from the mother. Sequencing of RT–PCR products
obtained with primers in exon 2B and exon 3 only showed the paternally derived C allele.
doi:10.1371/journal.pgen.1000790.g003
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skewing most likely results from the fact that in some cells the
paternal allele has gained methylation and now resembles the
maternal allele. In summary, these results demonstrate that there is
a link between allele-specific methylation of CpG 85 and allelic
expression imbalance of RB1, although they can not provide
evidence in favour of a specific mechanism.
We also investigated allelic Rb1 expression levels in mice, which
do not have the intronic CpG island. For this, we crossed FVB and
C3H mice, which differ by a single nucleotide (T/C) in exon 25
Table 1. Expressed variants in the RB1 gene.
Fam. ID Individuals Location of variants Genome (L11910) Protein Comment Blood available LCs available
A II-1 exon 3 g.39522C.T p.Ser114Leu missense 33
III-1 33
B III-1 exon 9 g.61788C.T p.Thr307Ile missense 33
C II-1 exon 12 g.70329C.T p.Asn405Asn samesense 3
III-2 3
D II-1 exon 18 g.150009A.G p.Leu569Leu samesense 3
III-2 3
E III-1 exon 21 g.160757T.C p.Cys712Arg missense oncogenic 3
III-2 3
F I-3 exon 21 g.160794T.G p.Ile724Ser missense 3
II-1 3
III-1 3
G II-1 exon 23 g.162333C.T p.Leu819Leu samesense 3
III-2 3
H II-1 exon 9 g.61788C.T p.Thr307Ile missense 3
III-1 3
doi:10.1371/journal.pgen.1000790.t001
Figure 5. Allelic expression imbalance of the RB1 gene. Plot of the ratio of allelic expression as determined by SNaPshot primer extension on
RT–PCR products obtained from RNA from blood of 14 individuals from 7 families informative for expressed variants (Table 1). The primer extension
assay for the variant in exon 3 (family A) only detects the regular transcript whereas the assays for the variants downstream of exon 3 (families B to G)
detect transcripts initiated in exon 2B in addition to regular transcripts. Of note, direction and extent of skewing in family A are not different from that
in the other families and, therefore, the relative abundance of 2B-transcripts compared to regular transcripts is likely to be low. For each sample 3–5
independent experiments were performed. The top and bottom of the means diamonds represent the 95% confidence intervals for the means.
Squares, male individuals; circles, female individuals; filled symbols, bilateral retinoblastoma; half-filled symbols, unilateral retinoblastoma; open
symbols, unaffected. Asterisk marks individuals in whom parental origin of alleles is unknown.
doi:10.1371/journal.pgen.1000790.g005
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FVBxC3H and four C3HxFVB offspring by primer extension
analysis. The maternal/paternal transcript ratios were 0.69613%
(mean6SD) and 1.49613%, respectively, which indicate strain-
specific effects but no parent-of-origin specific effects on Rb1 gene
expression. This finding strengthens the notion that parent-of-
origin specific expression imbalance of the human RB1 gene is
dependent on the presence of the differentially methylated
CpG 85.
One possible mechanism for this link is transcriptional
interference. As described above, after demethylation of CpG 85
transcription from the maternal 2B-promoter is activated and the
RB1 expression imbalance is reduced. Possibly, the transcription
complex binding to the 2B-promoter acts as a road block for the
regular transcript [17]. The absence of a quantitative correlation
between the amount of the 2B-transcript and the degree of the
reduction in skewing may to some extent be due to the fact that
2B-transcript levels are very low and difficult to quantify.
However, it may also indicate that the assembly of the
transcription complex at the 2B-promoter is more important than
the actual transcription.
Another conceivable mechanism is enhancer blocking. Similar
to the situation at the IGF2/H19 locus [18,19], the unmethylated
CpG 85 may bind CTCF or some other insulator protein and
block the interaction between the regular RB1 promoter and a
downstream enhancer. So far, however, no such enhancer has
been identified, and the RB1 locus does not contain any
experimentally determined in vivo CTCF-binding site [20].
In summary, we have shown that parent-of-origin dependent
expression imbalance of the RB1 gene is linked to the insertion of a
59-truncated, processed pseudogene, which acquired a differentially
methylated CpG island. Our findings extend the observations on
Figure 6. Treatment of lymphoblastoid cells (LCs) with the demethylation drug 5-aza-29-deoxycytidine (AzadC). (A) Methylation
analysis of CpG 85 by methylation-specific PCR (MS-PCR) and quantification of allelic expression imbalance of the RB1 gene. The top chart shows the
methylation status of CpG 85 in blood, mock-treated and AzadC-treated LCs. The percentage of MS-PCR products specific for methylated and
unmethylated alleles is indicated by black and grey bars, respectively. The bottom plot shows the ratio of allelic expression as determined by
SNaPshot primer extension on RT–PCR products obtained from RNA. For each sample 3–8 independent experiments were performed. The top and
bottom of the means diamonds represent the 95% confidence interval for the means. In family H, we could not investigate allelic RB1 expression in
blood, because we did not have RNA from fresh blood. In this family, a male patient with unilateral retinoblastoma (HII-1) inherited the rare variant
from his unaffected mother and transmitted it to his unaffected daughter (HIII-1). (B) Electropherograms of SNaPshot primer extension on RT–PCR
products specific for the 2B-transcript. Black and red peaks correspond to C and T alleles, respectively. In A III-1, the C allele is known to be of paternal
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sposons [15,21,22] to include truncated processed pseudogenes and
support the notion that genomic imprinting builds on host defence
mechanisms [23–26]. A very good example in support of the latter
hypothesis is the imprinted PEG10 gene, which shares homology
with an LTR-type retrotransposon, sushi-ichi [27]. Unlike PEG10,
however, the DNA sequence inserted into the RB1 gene is derived
from an endogenous gene (KIAA0649). This appears to be true also
fortheimprintedZrsr1(U2af1-rs1),Nap1l5,Inpp5f_v2andMcts2genes,
which are located within introns of other genes [15,22]. These genes
are active, independent genes that are likely to encode a protein. In
contrast, the KIAA0649 cDNA fragments must have been dead on
arrival, because they lack the 59-end. They have lost the ORF, and
CpG 85 is located within the former ORF. The chromosome 22
copies do not have a CpG island. Thus, the site of integration has
determined the evolutionary fate of the cDNA copies.
Of note, the direction of the imprint imposed on the RB1 gene is
the same as of the maternally expressed CDKN1C gene, which
encodes a cyclin-dependent kinase inhibitor operating upstream of
pRb [28]. The imprinting of two components of the same pathway
(CDKN1C and RB1) indicates that there has been evolutionary
selection for maternal inhibition of cell proliferation. Neither
CDKN1C [28] nor RB1 expression (this work) is strictly
monoallelic, probably because complete imprinting would make




The study was approved by the ethics committee of the
University Hospital Essen. Blood was obtained after informed
consent was given.
Clinical description
The proband was born after 32 weeks with a weight and length
at the 3
rd percentile and a head circumference between the 10
th
and 25
th percentiles. After birth umbilical hernia, patent ductus
arteriosus requiring surgery, and facial dysmorphism were noted.
He has global developmental delay.
DNA preparation
Human DNA was extracted from blood and lymphoblastoid
cells with the FlexiGene DNA Kit (Qiagen, Hilden, Germany)
following the manufacturer’s instructions. Mouse tail DNA was
extracted with the help of EZ1 DNA Tissue Kit for use on the
BioRobot EZ1 (Qiagen, Hilden, Germany).
Bisulfite treatment of genomic DNA
Bisulfite treatment of genomic DNA was performed as
described by Kanber et al. [29].
DNA cloning
PCR products derived from the bisulfite converted DNA were
cloned into the pGEM-T easy vector (Promega, Madison, USA). For
PCR tagged primers were used: RB1-Ftag; RB1-RM13 (Table S1).
PCR conditions were as follows: 95uC for 10 min, 35 cycles of 95uC
for 20 sec, 56uC for 20 sec, 72uC for 30 sec, finally 72uCf o r7m i n .A
numberof .24 cloneswere picked and analyzed by DNA sequencing.
DNA methylation profiling using universal BeadArrays
Bisulfite conversion of the DNA was performed using the
‘‘Zymo EZ DNA Methylation Kit’’ (Zymo Research, Orange, CA)
according to the manufacturer’s procedure with the modifications
described in the ‘‘Infinium Assay Methylation Protocol Guide’’
(Illumina Inc., San Diego, CA). All further analysis steps were
performed according to the ‘‘Infinium II Assay Lab Setup und
Procedures’’ and the ‘‘Infinium Assay Methylation Protocol
Guide’’ (Illumina Inc.). The processed DNA samples were
hybridized to the ‘‘HumanMethylation27 DNA Analysis Bead-
Chip’’ (Illumina Inc., San Diego, CA). This array was developed
to assay 27,578 CpG sites selected from more than 14,000 genes.
Data analysis was performed using BeadStudio software (version
3.1.3.0, Illumina Inc.) using default settings.
DNA sequencing
Sequence reactions were performed with Big Dye Terminators
(BigDye Terminator v1.1 Cycle Sequencing Kit, Applied Biosys-
tems, Foster City, CA, USA) and the cycle sequencing procedure.
Reaction products were analyzed with an ABI 3100 automatic
capillary Genetic Analyzer and Sequencing Analysis software
(Applied Biosystems, Foster City, CA, USA).
Methylation-specific PCR
The amplification reaction contained 1 ml bisulfite converted
DNA in a final volume of 25 ml. Primers used were: RB1-MF,
RB1-MR, RB1-UF and RB1-UR (Table S1). Reaction conditions
were 95uC for 10 min, 35 cycles of 95uC for 30 sec, 58uC for
30 sec and 72uC for 30 sec, finally 30 min at 72uC. Methylated
(maternal) and unmethylated (paternal) product sizes were 126 bp
and 119 bp, respectively. PCR products were analyzed on an ABI
3100 Genetic Analyzer.
RNA preparation
RNA from peripheral human and mouse blood was extracted
with either PAXgene blood RNA Kit (PreAnalitiX, Hombrechti-
kon, Schweiz) or QIAamp RNA Blood Mini Kit (Qiagen, Hilden,
Germany). RNA from lymphoblastoid cells was extracted with the
RNeasy Mini Kit (Qiagen, Hilden, Germany) following the
manufacturer’s instructions. To remove residual traces of genomic
DNA, the RNA was treated with DNase I (Qiagen, Hilden,
Germany).
Reverse transcriptase PCR
RT–PCRs were performed with the GeneAmp RNA PCR Kit
(Applied Biosystems, Foster City, CA, USA). Total RNA from the
patients’ blood or lymphoblastoid cells was reverse transcribed
with random hexamers. For amplification, the Advantage cDNA
Polymerase Mix (Clontech, Mountain View, CA, USA) and the
GoTaq DNA Polymerase Kit (Promega, Madison, USA) were
used. PCR products were checked on an agarose gel and purified
either by MultiScreen Filtration (Milllipore, Billerica, MA, USA)
or by gel extraction (Wizard SV Gel and PCR Clean-Up System,
Promega; QIAquick Gel Extraction Kit, Qiagen). The primers
used for the different RT–PCRs are listed in Table S1 and Table
S2. For exon connection PCR we designed primers where the
forward primer anneals to the CpG island (CpG85-fw) and the
reverse primer anneals to exon 4 of the RB1 gene (RB1-Exon4-rev,
Table S1). For amplification we used the Advantage cDNA
Polymerase Mix (Clontech, Mountain View, CA, USA). PCR
conditions were as follows: 95uC for 1 min, 35 cycles of 95uC for
20 sec, 64uC for 3 min, and finally 3 min at 68uC. For establishing
an expression profile of the alternative RB1 transcript, total RNA
from several tissues (Human Total RNA Master Panel II,
Clontech, Mountain View, CA, USA) and blood RNA from a
normal control was used for the RT–PCR with primers in exon 2B
Imprinting of RB1
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was performed on Marathon-Ready cDNA (Clontech, Mountain
View, CA, USA).
Rapid amplification of 59 cDNA ends (59RACE)
The 59RACE was carried out with the 59/39 RACE Kit (2
nd
Generation, Roche, Mannheim, Germany) following the manu-
facturer’s instructions – except of the first-strand cDNA synthesis
step. We performed RT–PCR for cDNA synthesis as described
above and continued with the next step of the RACE protocol
(cDNA purification). Primers used are given in Table S1.
Cell culture
Lymphoblastoid cells were established by Epstein-Barr virus
(EBV) transformation of peripheral blood lymphocytes from the
patients and their family members as well as from a normal
control. Cells were grown in RPMI 1640 medium with 10% fetal
calf serum and 1% penicillin/streptomycin at 37uC.
Treatment with 5-aza-29-deoxycytidine (AzadC)
Cells were counted and seeded at an initial concentration of
2.5–3610
5 cells/ml in a total volume of 10 ml per flask. The
medium was changed every 24 h. A 10 mM stock solution of
AzadC (Sigma, St. Louis, MO, USA) was prepared in sterile water
and stored in aliquots at 280uC. A daily dose of AzadC (0.5 mM)
was added to the flask, whereas control flasks received an identical
volume of water. Cells were harvested after 96 h treatment and
RNA and DNA were extracted.
Primer extension analysis
A single nucleotide primer extension method was applied to
measure allelic ratios of mRNA (after conversion to cDNA) and
genomic DNA (as reference). Using equal amounts of amplicons
from cDNA and genomic DNA, quantitative primer extension
assay was carried out with ABI Prism SNaPshot ddNTP Primer
Extension Kit (Applied Biosystems, Foster City, CA, USA). The
SNaPshot reaction products were analyzed by gel capillary
electrophoresis on ABI 3700 (Applied Biosystems, Foster City,
CA, USA) and electropherograms were analyzed with the Gene
Mapper 4.0 software. Allelic DNA ratios were used to normalize
the cDNA ratios. Sequences of primers for PCR as well as for
SNaPshot are given in Table S2. Means and confidence intervals
were calculated with JMP7 (SAS, Cary, NC, USA).
Supporting Information
Table S1 Primer sequences used for DNA cloning, RT-PCR,
methylation-specific PCR, and 59RACE experiments.
Found at: doi:10.1371/journal.pgen.1000790.s001 (0.04 MB
DOC)
Table S2 Primer sequences for PCR and primer extension
analysis.
Found at: doi:10.1371/journal.pgen.1000790.s002 (0.07 MB
DOC)
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